Monopar Therapeutics Inc's total assets for Q1 2025 were $55.09M, a decrease of -8.63% from the previous quarter. MNPR total liabilities were $1.49M for the fiscal quarter, a -71.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.